ENVALITH
中外製薬株式会社 logo

CHUGAI PHARMACEUTICAL CO., LTD.

4519Prime MarketPharmaceuticals

中外製薬株式会社 logo
CHUGAI PHARMACEUTICAL CO., LTD.4519
Reference Indicators

Market Cap

123,360¥100M

P/E (Forecast)

P/B

6.0x

Dividend Yield (Forecast)

1.80%

ROE

21.4%

EV/EBITDA

Financial Summary
Unit: ¥M
Item
2021Dec 2021
2022Dec 2022
2023Dec 2023
2024Dec 2024
2025Dec 2025
Net Sales
999,7591,259,9461,111,3671,170,6111,257,941
Cost of Sales
338,147476,251413,306339,409363,690
Gross Profit
661,612783,695698,061831,201894,251
SG&A Expenses
112,580110,098116,461
Operating Income
421,897533,309439,174542,002598,833
Pre-tax Income
419,385531,166443,821543,034597,807
Income Taxes
116,390156,737118,349155,717163,794
Net Income
302,995374,429325,472387,317434,012
Gross Margin
66.2%62.2%62.8%71.0%71.1%
Operating Margin
42.2%42.3%39.5%46.3%47.6%
ROA
19.7%20.0%16.8%17.5%17.6%
ROE
25.5%26.3%20.0%20.4%21.4%